Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered
Human content, AI powered search.

Latest Stories

Search

Human content, AI powered search.

Search Results for NICE

NICE update on technology to diagnose endometriosis
News

NICE update on technology to diagnose endometriosis

The committee now recommends that only Endotest, a saliva-based test that detects a microRNA biomarker signature, can be used in the NHS

NICE recommends 'artificial pancreas' device for pregnant women with type 1 diabetes
News

NICE recommends 'artificial pancreas' device for pregnant women with type 1 diabetes

The pregnancy-specific hybrid closed loop system automatically monitors blood sugar and delivers insulin to maintain safer blood sugar levels throughout pregnancy

UK-US medicine deal
News

UK-US medicine deal could undermine NICE independence: Campaigners

Two campaign groups claim that changes in NHS laws could help government override NICE decisions

NICE approves givinostat Duchenne muscular dystrophy
Drug Safety & Medicine Alerts

Hope for Duchenne muscular dystrophy patients as NICE approves givinostat

Around 530 people in England will benefit from givinostat following the successful negotiation of a commercial deal to make the medicine available on the NHS

Myasthenia gravis
News

NICE endorses first treatment for Myasthenia gravis

Nearly, 800 people in the UK suffer from this rare autoimmune condition with no cure

Dr Adrian Hayter appointed chief medical officer at NICE
News

Dr Adrian Hayter appointed chief medical officer at NICE

He has thirty years of frontline clinical and national leadership experience

NICE approves drug bile duct cancer
Drug Safety & Medicine Alerts

NICE approves life-extending drug for rare bile duct cancer patients

The recommendation is an important step in the treatment of bile duct cancer, as it is often diagnosed late, when surgeries are impossible

NICE Raises Cost-Effectiveness Thresholds
News

NICE increases cost-effectiveness thresholds for healthcare decisions

The move is expected to incentivise pharmaceutical companies to launch innovative treatments in the UK